RxSight, Inc.RXSTNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank67
3Y CAGR+4.4%
5Y CAGR+19.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+4.4%/yr
Annual compound
5Y CAGR
+19.4%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$31.47M-23.2%
2024$40.98M+16.1%
2023$35.31M+27.6%
2022$27.68M+53.1%
2021$18.08M+39.3%
2020$12.97M+219.5%
2019$4.06M-